Showing results (481-490 of 2,355) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|September 19, 2012
Antipsychotics and abnormal liver function tests: systematic reviewKatie F M Marwick, Mark Taylor, Simon W Walker
Clinical Neuropharmacology|July 4, 2012
Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot studySimone Di Rezze, Vittorio Frasca, Maurizio Inghilleri, et al.
Clinical Neuropharmacology|August 31, 2012
Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trialsRobert B Chinnapongse, Mark F Lew, Joaquim J Ferreira, et al.
Clinical Neuropharmacology|July 19, 2012
Diminished brain functional magnetic resonance imaging activation in patients on opiate maintenance despite normal spatial working memory task performancePatrick Bach, Sabine Vollstädt-Klein, Ulrich Frischknecht, et al.
Clinical Neuropharmacology|December 1, 1990
Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeysJ M Cedarbaum, G Léger, A Reches, et al.
Clinical Neuropharmacology|February 1, 1991
Serotonin receptor subtypes: functional, physiological, and clinical correlatesP L Bonate
Clinical Neuropharmacology|February 1, 1989
A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuationsR J Coleman, J A Temlett, N P Quinn, et al.
Clinical Neuropharmacology|January 1, 1985
Dystonia: treatment with bromocriptineR P Newman, P A LeWitt, C Shults, et al.
Clinical Neuropharmacology|February 1, 1990
Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine. A double-blind, placebo-controlled study in young healthy volunteersM Juvent, J Douchamps, E Delcourt, et al.
Clinical Neuropharmacology|February 1, 1990
Influence of tetrahydro-9-aminoacridine on excitatory amino acid releaseA M Palmer, J E Steele, S L Lowe, et al.
Pageof 236